Arete Wealth Advisors »

Iovance Biotherapeutics shares owned by Arete Wealth Advisors

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Arete Wealth Advisors from 13F filings

Historical chart of Arete Wealth Advisors investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Arete Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Arete Wealth Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $325k 35k 9.39
2024-03-31 $1.0M 69k 14.82
2023-12-31 $1.8M 216k 8.13
2023-09-30 $150k 33k 4.55
2023-06-30 $91k 13k 7.05

More positions owned by Arete Wealth Advisors

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Walt Disney Company (DIS)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
NVIDIA Corporation (NVDA)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Vaneck Etf Trust Ig Floating Rate (FLTR)
Spdr Ser Tr Portfolio Agrgte (SPAB)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Microsoft Corporation (MSFT)
Ishares Tr Eafe Value Etf (EFV)
Spdr Gold Tr Gold Shs (GLD)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Amazon (AMZN)

View all positions for Arete Wealth Advisors

Top funds holding Iovance Biotherapeutics

Perceptive Advisors
Vanguard Group
MHR Fund Management
BlackRock
BlackRock
State Street Corporation
Soleus Capital Management
T. Rowe Price Investment Management
Geode Capital Management
Artisan Partners Limited Partnership
Balyasny Asset Management
Long Focus Capital Management
Principal Financial Group
T. Rowe Price Associates
Palo Alto Investors

View all funds holding Iovance Biotherapeutics